Beyond cancer, SETDB1 appears to be involved in immune modulation observed in autoimmune diseases such as immune thrombocytopenia (ITP), where the transcriptional levels of human ERVs correlate with those of TRIM28/SETDB1 [56]. This evidence concerns the gene TRIM28 and autoimmune thrombocytopenic purpura.